维普期刊资源整合服务平台（V6.5）

183篇 您的检索式：作者名="DAVIES FE"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	Thalidomide and immunomodu latory derivatives augment natural killer cell cytotoxicity in multiple myeloma显示文摘	Davies FE Raje N Hideshima T		0，，：	2
2	Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma显示文摘	Davies FE Raje N Hideshima T	2001	Blood2001，98，1：	1
3	Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas显示文摘	Gibbs FE Halliwell N	1999	Br J Cancer1999，79，：	1
4	High -dose chemotherapy with hematopietic stem - cell rescue for multiple myeloma 显示文摘	Child JA Morgan GJ Davies FE	2003	N Engl J Med2003，348，19：	1
5	Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxieity in multiple myeloma显示文摘	Davies FE Raje N Hideshima T	2001	Blood2001，98，1：	1
6	Long-term follow-up of MRC Myeloma IX trial: Survival outcomes with bisphosphonate and thalidomide treatment显示文摘	Morgan GJ Davies FE Gregory WM	2013	Clin Cancer Res2013，19，21：	1
7	The genetic architecture of multiple myeloma显示文摘	Morgan GJ Walker BA Davies FE	2012	Nat Rev Cancer2012，12，5：	1
8	Cyclophosphamide, thalidomide, and dexamethasone(CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation显示文摘	Morgan GJ Davies FE Gregory WM	2011	Blood2011，118，5：	1
9	Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multip lemyeloma显示文摘	Davies FE Raje N Hideshima T	2001	Blood2001，98，1：	1
10	The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis显示文摘	Morgan GJ Gregory WM Davies FE	2012	Blood2012，119，1：	1
11	Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma 显示文摘	Davies FE Raje N Hideshima T et ol	2001	Blood2001，98，1：	1
12	Expression of an epidermal keratin protein in liver of transgenic mice causes structural and functional abnormalities 显示文摘	Albers KM Davis FE Perrone TN	1995	J Cell Biol1995，28，12：	1
13	High producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression free survival after treatment显示文摘	Davies FE Rollinson SJ Rawstron AC	2000	J Clin Oncol2000，18，：	1
14	Thalidomide and immunomodulatory derivalives augment natural killer cell cytotoxicity in multiple myeloma显示文摘	Davies FE Raja N Hideshima T	2001	Blood2001，98，1：	1
15	The genetic architecture of multiple myeloma显示文摘	Morgan GJ Walker BA Davies FE	2012	Nat Rev Cancer2012，12，5：	1
16	Minimal residual dis-ease monitoring in multiple myeloma 显示文摘	Davies FE Rawstren AC Owen RG	2002	Best Pract Res Clin Haematol2002，15，1：	1
17	Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma 显示文摘	Davies FE Hideshima T	2001	Blood2001，98，：	1
18	Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma显示文摘	Davies FE Raje N Hideshima T	2001	Blood2001，98，1：	1
19	The combination of cyclophosphamide,velcade and dexamethasone induces high response rates with comparable toxicity to velcade alone and velcade plus dexamethasone显示文摘	DAVIES FE WU P JENNER M	2007	Haematologica2007，92，8：	1
20	High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma显示文摘	Child JA Morgan GJ Davies FE	2003	N Engl J Med2003，348，19：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示